KYORIN Pharmaceutica...
TSE:4569
¥ 1.660,00
¥-5,00 (-0,30%)
1.660,00 ¥
¥-5,00 (-0,30%)
End-of-day quote: 03/06/2026

Quick Analysis

¥0,00
Earnings Per Share
¥2,26k
Revenue Per Share
45,77%
Gross Margin %
¥95,66 B
Market Cap
¥20,24 B
Long-Term Debt
Earnings Per Share
¥0,00
Revenue Per Share
¥2,26k
Gross Margin %
45,77%
Market Cap
¥95,66 B
Long-Term Debt
¥20,24 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
EPS Earnings Per Share ¥158,17 ¥92,74 ¥82,44 ¥68,62 ¥106,99 ¥107,35 ¥104,68 ¥89,28 ¥99,45 ¥184,28 ¥161,63 ¥160,95 ¥166,25 ¥123,54 ¥146,21 ¥118,37 ¥27,24 ¥29,26 ¥64,97 ¥69,74
Earnings Earnings ¥9,09B ¥5,33B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
RPS Revenue Per Share ¥2,26k ¥0,00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Revenue Revenue ¥130,09B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
OCF Operating Cash Flow ¥3,51B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
FCF Free Cash Flow ¥-2,65B ¥-1,64B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
OM Operating Margin 9,65% 5,02% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 45,77% 43,01% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share ¥-48,51 ¥-81,84 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00
LT Debt Long-Term Debt ¥20,24B N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 57,46M 57,45M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M
×